Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-441 Cr₹-422 Cr₹818 Cr₹794 Cr₹3,977 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-441 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-441 Cr
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr
Mar2021₹3,977 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-441 Cr
Negative
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr
-80.03
Mar2021 ₹3,977 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,632.7 Cr -1.9% 4.9% -17.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,054.0 Cr 0.9% 6.2% -1.3% Stock Analytics
DIVIS LABORATORIES ₹167,075.0 Cr 2% 4.8% 4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,904.0 Cr 3.6% 6% 36.9% Stock Analytics
CIPLA ₹107,358.0 Cr -0.1% -3% -8.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,813.0 Cr 1% 10.8% 4.7% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-1.9%

4.9%

-17.3%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses